Tamron (7740) Q2 2026 earnings summary
Event summary combining transcript, slides, and related documents.
Q2 2026 earnings summary
7 Aug, 2026Executive summary
Pursuing transformation from a lens manufacturer to a comprehensive optical and sensing solutions provider, targeting sustainable corporate value growth by 2035.
Long-term vision emphasizes "Capture, Measure, Connect" for people and nature, focusing on healthcare, environmental sensing, and advanced optical technologies.
Net sales increased by 3.8% year-over-year to ¥43,281 million for Q2 FY2026.
Operating income declined by 16.5% year-over-year to ¥7,689 million.
Comprehensive income rose sharply by 63.3% year-over-year to ¥7,641 million.
Financial highlights
1H FY2026 net sales rose 4% year-over-year, driven by double-digit growth in industrial segments, offsetting a 20% drop in Photo OEM sales.
Operating profit fell 17% year-over-year due to lower high-margin Photo OEM revenue, cost inflation, and increased R&D and labor expenses.
Gross margin declined to 41.9% from 45.3% year-over-year.
Net income for 1H FY2026 was ¥6,197 million, up 8.7% versus forecast but down 9.9% year-over-year.
Total assets increased to ¥109,240 million from ¥106,046 million at FY2025 year-end.
Outlook and guidance
FY2026 net sales forecast revised upward to ¥93,000 million (+9.3% YoY), reflecting strong Automotive and Healthcare performance.
Operating income maintained at ¥18,500 million (+11.2% YoY), absorbing ongoing cost pressures.
Net income forecast at ¥13,690 million (+16.4% YoY); net income per share forecasted at ¥84.91 for FY2026.
Photographic Products expected to recover in 2H; industrial segments to sustain growth.
Latest events from Tamron
- Targets ROE of 20%+, ¥200B+ sales, and major growth in new businesses by 2029.7740
Investor presentation - Q1 FY2026 sales fell 5% but strong segments and currency gains support a positive full-year outlook.7740
Q1 2026 - FY2025 profits fell, but Q4 rebounded and FY2026 forecasts renewed growth and new launches.7740
Q4 2025 - Sales and profit fell, but full-year guidance projects modest growth and stable dividends.7740
Q3 2025 - Profits fell YoY in 1H FY2025, but cost controls drove outperformance versus forecasts.7740
Q2 2025 - Record sales and profits led to a raised FY2024 outlook and enhanced shareholder returns.7740
Q3 2024 - Sales and profits soared, with FY2024 outlook and dividends revised upward post stock split.7740
Q2 2024 - Sales and profits fell in 1Q FY2025, with guidance signaling continued challenges.7740
Q1 2025 - Record sales, double-digit profit growth, and new stock splits signal strong momentum.7740
Q4 2024